Real-world clinical course of HTLV-1-associated myelopathy/tropical spastic paraparesis (HAM/TSP) in Japan

Overview of attention for article published in Orphanet Journal of Rare Diseases, October 2019

Altmetric Badge

Citations

dimensions_citation: 21 Dimensions

Readers on

mendeley: 40 Mendeley

Summary Dimensions citations

So far, Dimensions has found 21 publications that cite this research output.

21

The most recent citing publications are shown below. View all 21 publications that cite this research output on Dimensions.

HTLV-1-Associated Myelopathy (HAM) Incidence in Asymptomatic Carriers and Intermediate Syndrome (IS) Patients

Article in Pathogens (May 2024)

Multicenter, randomized, double-blind, placebo-controlled phase 3 study of mogamulizumab with open-label extension study in a minimum number of patients with human T-cell leukemia virus type-1-associated myelopathy

Article in Journal of Neurology (March 2024)

Mycophenolate mofetil for the long-term treatment of HTLV-1 associated myelopathy: A case report

Article in Journal of Neuroimmunology (January 2024)

This page shows the most recent citations of this research output.

Click here to find out how to access more activity.